0001209191-16-126674.txt : 20160608 0001209191-16-126674.hdr.sgml : 20160608 20160608203417 ACCESSION NUMBER: 0001209191-16-126674 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160607 FILED AS OF DATE: 20160608 DATE AS OF CHANGE: 20160608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dimension Therapeutics, Inc. CENTRAL INDEX KEY: 0001592288 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463942159 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-401-0011 MAIL ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clark K. Reed CENTRAL INDEX KEY: 0001653061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37601 FILM NUMBER: 161704771 MAIL ADDRESS: STREET 1: C/O DIMENSION THERAPEUTICS, INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-07 0 0001592288 Dimension Therapeutics, Inc. DMTX 0001653061 Clark K. Reed C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE, 4TH FLOOR CAMBRIDGE MA 02139 0 1 0 0 SVP of Pharmaceutical Develop Common Stock 2016-06-07 4 M 0 5000 0.38 A 5000 D Common Stock 2016-06-07 4 S 0 5000 10.00 D 0 D Stock Option (Right to Buy) 0.38 2016-06-07 4 M 0 5000 0.00 D 2024-04-21 Common Stock 5000 114739 D This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This stock option vests over four (4) years beginning on April 1, 2014, at a rate of twenty-five percent (25%) after 12 months, and in thirty-six (36) equal monthly installments thereafter. /s/ Jean Franchi, as Attorney-in-Fact for K. Reed Clark 2016-06-08